248 related articles for article (PubMed ID: 33414832)
1. Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2.
Juárez-Navarro KJ; Padilla-Camberos E; Díaz NF; Miranda-Altamirano A; Díaz-Martínez NE
Stem Cells Int; 2020; 2020():8892189. PubMed ID: 33414832
[TBL] [Abstract][Full Text] [Related]
2. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
[TBL] [Abstract][Full Text] [Related]
5. Safety and Effectiveness of Intravascular Mesenchymal Stem Cells to Treat Organ Failure and Possible Application in COVID-19 Complications.
Atluri S; Manocha V; Boddu N; Bhati S; Syed Z; Diwan S; Manchikanti L
Pain Physician; 2020 Aug; 23(4S):S391-S420. PubMed ID: 32942796
[TBL] [Abstract][Full Text] [Related]
6. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives.
Liang X; Ding Y; Zhang Y; Tse HF; Lian Q
Cell Transplant; 2014; 23(9):1045-59. PubMed ID: 23676629
[TBL] [Abstract][Full Text] [Related]
7. Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm.
Yin K; Wang S; Zhao RC
Biomark Res; 2019; 7():8. PubMed ID: 30992990
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell derived extracellular vesicles: promising immunomodulators against autoimmune, autoinflammatory disorders and SARS-CoV-2 infection.
Bulut Ö; GÜrsel İ
Turk J Biol; 2020; 44(3):273-282. PubMed ID: 32595362
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease.
Yun CW; Lee SH
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813471
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy.
Sleem A; Saleh F
Curr Res Transl Med; 2020 Aug; 68(3):105-110. PubMed ID: 32616467
[TBL] [Abstract][Full Text] [Related]
11. Exosomes/miRNAs as mediating cell-based therapy of stroke.
Xin H; Li Y; Chopp M
Front Cell Neurosci; 2014; 8():377. PubMed ID: 25426026
[TBL] [Abstract][Full Text] [Related]
12. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
Tovar I; Guerrero R; López-Peñalver JJ; Expósito J; Ruiz de Almodóvar JM
Cells; 2020 Sep; 9(9):. PubMed ID: 32887260
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs.
Qiu G; Zheng G; Ge M; Wang J; Huang R; Shu Q; Xu J
Stem Cell Res Ther; 2018 Nov; 9(1):320. PubMed ID: 30463593
[TBL] [Abstract][Full Text] [Related]
14. Additive effect of bFGF and selenium on expansion and paracrine action of human amniotic fluid-derived mesenchymal stem cells.
Park J; Lee JH; Yoon BS; Jun EK; Lee G; Kim IY; You S
Stem Cell Res Ther; 2018 Nov; 9(1):293. PubMed ID: 30409167
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
Gorman E; Millar J; McAuley D; O'Kane C
Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
[No Abstract] [Full Text] [Related]
16. Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes.
Lee BC; Kang I; Yu KR
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33670202
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.
Harrell CR; Gazdic M; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Curr Stem Cell Res Ther; 2019; 14(4):327-336. PubMed ID: 30806325
[TBL] [Abstract][Full Text] [Related]
18. Emerging Role of Mesenchymal Stem Cell-derived Exosomes in Regenerative Medicine.
Zhao T; Sun F; Liu J; Ding T; She J; Mao F; Xu W; Qian H; Yan Y
Curr Stem Cell Res Ther; 2019; 14(6):482-494. PubMed ID: 30819086
[TBL] [Abstract][Full Text] [Related]
19. Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart Disease.
Ward MR; Abadeh A; Connelly KA
Stem Cells Transl Med; 2018 Jul; 7(7):543-550. PubMed ID: 29665255
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria in mesenchymal stem cell biology and cell therapy: From cellular differentiation to mitochondrial transfer.
Hsu YC; Wu YT; Yu TH; Wei YH
Semin Cell Dev Biol; 2016 Apr; 52():119-31. PubMed ID: 26868759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
